We are live on ! Find out more
PRTC

PureTech Health

Delisted

PRTC was delisted on the 20th of May, 2026.

5 hedge funds and large institutions have $1.58M invested in PureTech Health in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.03% less ownership

Funds ownership: 0.42%0.39% (-0.03%)

16% less capital invested

Capital invested by funds: $1.88M → $1.58M (-$299K)

17% less funds holding

Funds holding: 65 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
1
Pentwater Capital Management
Florida
$1.16M -$85.8K -5,000 -7%
Millennium Management
2
Millennium Management
New York
$266K -$41.3K -2,406 -13%
DP
3
Diadema Partners
New Jersey
$124K +$2.03K +118 +2%
PAP
4
Persistent Asset Partners
Hong Kong
$29.4K +$1.27K +74 +4%
UBS Group
5
UBS Group
Switzerland
$334
SS
6
SBI Securities
Japan
-$37 -2 Closed

PRTC Hedge Fund Activity: Q4 2025 in Review

5 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2025, worth a combined $1.58M — down 16% from $1.88M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PRTC and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.

The largest buyer was Diadema Partners, adding an estimated $2.03K. The largest seller was Pentwater Capital Management, cutting an estimated $85.8K.

  • 5 institutional investors held PureTech Health (PRTC) as of Q4 2025, down from 6 in Q3 2025.
  • Funds reported $1.58M of PureTech Health stock for Q4 2025, down 16% quarter-over-quarter.
  • 0 funds opened new PureTech Health positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest PureTech Health buyer in Q4 2025 was Diadema Partners, an estimated $2.03K added.
  • The largest PureTech Health seller in Q4 2025 was Pentwater Capital Management, an estimated $85.8K sold.

Based on aggregated 13F filings for Q4 2025.